Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Newcrest Mining Ltd. announced it has increased its stake in Lundin Gold Inc. (LUG-T) by 4.9 per cent to 32 per cent.

It purchased the shares from Kinross Gold Corp. (K-T) for $7.25 per share or $79.6-million at a 4.2-per-cent discount to last trade price.

Story continues below advertisement

“This was a great opportunity to increase our exposure to Fruta del Norte, a Tier 1 asset, which is expected to commence commercial production in the June 2020 quarter,” said Newcrest CEO Sandeep Biswas said in a statement.

Newcrest last year paid $250 million for a 27.1% stake in Lundin, which owns a high-potential gold mine project in Ecuador.

-with a file from Reuters

**

Roots Corp. (ROOT-T) says its third-quarter earnings dipped from last year to come in below its own target range as it faces a number of challenges.

The clothing brand says it had a net income of $1.97-million, or five cents per share in the quarter ending Nov. 2, down from $2.8-million or seven cents per share for the same quarter last year.

Analysts had expected earnings of $4.3-million, or eight cents per share, according to financial markets data firm Refinitiv.

Story continues below advertisement

Company CEO Jim Gabel says downward pressure on earnings has come from inefficiencies, U.S. stores performing "well-below" expectations, and macroeconomic headwinds at its Asia business.

Roots says that given its operational headwinds, and the "compressed holiday selling season" due to a later U.S. Thanksgiving, it now expects sales and net income for the fourth quarter will also be below its previous guidance.

-The Canadian Press

**

CannTrust Holdings Inc. (TRST-T; CTST-N) said in its latest required status update that it was either served or became aware of “putative class action lawsuits” against the company and certain of its current and former directors, officers, and employees relating to the drop in its share price after July 8.

The company said it expects the number of putative class actions against it to be consolidated in the coming months. "Recently, the company became aware of a lawsuit by Zola Finance Holdings Ltd. and Igor Gimelshtein that also relates to the drop in its share price after July 8, 2019," it stated. It said the total amounts claimed in the lawsuits "overlap and have not been quantified at the present time" and that it hasn't currently recorded any uninsured amount related to this contingency.

Story continues below advertisement

**

Taseko Mines Ltd. (TKO-T) announced that it has entered into a dialogue, facilitated by the B.C. government, with the Tŝilhqot’in Nation to try to obtain a long term solution to the conflict regarding the company’s proposed New Prosperity mine. The company said the dialogue acknowledges its commercial interests and the Tŝilhqot’in Nation’s opposition to the project. “While the details of this process are confidential, in order to facilitate a dialogue the parties have agreed to a standstill on certain outstanding litigation and regulatory matters which relate to Taseko’s tenures and the area in the vicinity of Teztan Biny (Fish Lake),” the company stated.

**

Sierra Wireless (SWIR-Q; SW-T) announced that its chief financial officer Dave McLennan is retiring after 16 years in the role. He’s expected to retire in mid-2020, after a replacement is found.

**

Medicure Inc. (MPH-X) announced that its subsidiary, Medicure International Inc., has filed a patent infringement action against Nexus Pharmaceuticals, Inc. in the U.S. District Court for the Northern District of Illinois. The company said the action is in response to Nexus’ filing of an abbreviated new drug application seeking approval from the U.S. Food and Drug Administration to market a generic version of its Aggrastat injection. “Medicure will vigorously defend the ’660 patent and will pursue the patent infringement action against Nexus and all other legal options available to protect its product,” the company stated.

Story continues below advertisement

In a separate release, the company said it has reached a settlement agreement with the purchaser of its interests in Apicore related to amounts held back under the Apicore sale agreement. “A settlement agreement was reached under which Medicure will receive a net payment of US$5.1-million in relation to the holdback,” the company stated.

Related topics

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies